Equipoise Cycle: Results, Dosage, and Side Effects

Equipoise, known chemically as Boldenone Undecylenate, is one of the more discussed injectable steroids in competitive bodybuilding. Originally developed as a veterinary compound for horses and cattle, it has been widely reported among bodybuilders for its ability to produce gradual, sustainable muscle gains and recovery with a comparatively mild estrogenic profile.

This guide covers everything regularly reported about an Equipoise cycle: what it is, how it is typically stacked with testosterone, the results users describe, dosages, side effects, and why post-cycle therapy is essential.

What Is Equipoise?

Equipoise is the trade name for Boldenone Undecylenate, an oil-suspended anabolic-androgenic steroid derived from testosterone. Its molecular structure is almost identical to Dianabol (Methandrostenolone), with one significant difference: it lacks the 17α-alkyl group and instead carries a long undecylenate ester, making it highly oil-soluble and giving it a slow, sustained release profile.

The double bond at carbon positions 1 and 2 makes Equipoise one of the least androgenic steroids available and substantially reduces its rate of aromatization, which refers to the conversion of testosterone into estrogen. This is why many users report lower rates of estrogenic side effects compared to compounds like straight testosterone or Deca-Durabolin.

How does Equipoise differ from Deca-Durabolin?

Despite being called a “poor man’s Deca” in some circles, Equipoise and Deca-Durabolin (Nandrolone Decanoate) have meaningfully different mechanisms. EQ does not carry the progestogenic activity associated with Deca, and its estrogenic pathway is lower. The slow-release ester on both compounds produces a comparable injection frequency, but the hormonal activity and side-effect profile differ.

What Is a Testosterone Equipoise Cycle?

A testosterone-Equipoise cycle combines Boldenone Undecylenate with a testosterone base (most commonly Testosterone Cypionate) to maximize muscle-building while providing the testosterone the body requires when endogenous production is suppressed. Testosterone is the standard base in most injectable steroid protocols because it prevents the hormonal deficiency symptoms that occur when natural testosterone is shut down.

Three common cycle structures are reported in the bodybuilding community:

Bulking Cycle (12 Weeks)

Testosterone Cypionate + Equipoise + Arimidex (aromatase inhibitor)

The aromatase inhibitor (Arimidex) is included to manage the mild estrogenic activity from both compounds. Dosages and duration should always be discussed with a medical professional.

Cutting Cycle 1 (12 Weeks)

Test-E + Equipoise + Dianabol (weeks 1–6) + HGH + Arimidex

Cutting Cycle 2 (12 Weeks)

Testosterone Propionate + Equipoise + Anavar (weeks 7–10) + Arimidex

Equipoise Cycle Results: What to Expect

Users who have reported on Equipoise cycles consistently describe the following pattern: gains are slower to appear than with more potent steroids, but they are leaner and more sustainable. Unlike mass-builders such as Anadrol or high-dose testosterone, Equipoise does not typically produce large amounts of water retention, which means the muscle gained tends to look drier and more defined.

Timeline of reported results

• Weeks 1–3: Increased energy, improved training endurance, heightened vascularity beginning to appear.
• Weeks 4–6: Noticeable strength increases; muscle fullness begins to develop.
• Weeks 8–12: Significant lean muscle accumulation; improved muscle definition and vascularity; fat loss if caloric intake is controlled.

Some users report gains of up to 15–30 lbs of muscle over a 12-week cycle when combined with an appropriate training programme and caloric surplus. Results vary considerably based on diet, training, individual response, genetics, and whether additional compounds are used.

Does Equipoise cause water retention?

Compared to aromatizing steroids like testosterone or Deca-Durabolin, Equipoise aromatizes at a lower rate, resulting in less water retention. This makes it popular for both bulking (where cleaner gains are preferred) and cutting (where excess water would obscure muscle definition).

Equipoise Effects and Benefits

1. Steady lean muscle growth

Equipoise stimulates nitrogen retention and protein synthesis in muscle tissue. Unlike faster-acting steroids, the gains accumulate gradually but are reported to be of higher quality — less water, more structural muscle. This is attributed to its low aromatization rate and the long ester providing sustained serum levels.

2. Enhanced red blood cell production

One of the more clinically documented effects of Boldenone is erythropoiesis stimulation — the increase of red blood cell production. More red blood cells means improved oxygen delivery to muscle tissue, which translates directly to better endurance, reduced fatigue during training, and faster aerobic recovery. This is one reason EQ is reported more frequently in endurance and athletic performance contexts, not just bodybuilding.

3. Improved athletic performance and endurance

The combination of increased red blood cell production, boosted metabolism, and elevated nitrogen retention collectively improves an athlete’s work capacity. Users report being able to train at higher intensity for longer before fatigue sets in. Strength increases, though typically more modest than with compounds like Trenbolone or high-dose testosterone.

4. Fat loss support

Equipoise’s metabolic effects and its ability to preserve lean muscle during a caloric deficit make it a reported choice for cutting phases. Bodybuilders preparing for competition often include it to retain muscle while in a calorie deficit. It does not directly burn fat, but improved muscle preservation and metabolism indirectly facilitate leaner body composition over a cycle.

5. Medical research context

Beyond bodybuilding, Boldenone has been investigated in research for potential applications in muscle-wasting conditions and osteoporosis. Its comparatively mild androgenic profile and lower estrogenic activity made it a candidate for therapeutic study, though it is not approved for human use in most countries.

Equipoise Cycle Side Effects

1. Estrogenic effects

Despite aromatizing at a lower rate than testosterone, Equipoise is not estrogen-neutral. Possible estrogenic effects include water retention, elevated blood pressure, and gynecomastia (breast tissue development in men) in susceptible individuals. An aromatase inhibitor such as Arimidex (Anastrozole) is typically included in cycles for this reason.

2. Androgenic effects

Androgenic side effects, like oily skin, acne, and accelerated hair loss in those genetically predisposed, are possible. However, Equipoise’s low androgenicity makes these less pronounced than with many other injectable steroids.

3. Cardiovascular strain

Anabolic steroids, including Equipoise, can negatively affect cardiovascular health. Reported concerns include elevated LDL (“bad”) cholesterol, suppressed HDL (“good”) cholesterol, raised blood pressure, and increased red blood cell count (which, in excess, raises blood viscosity). Individuals with pre-existing cardiovascular conditions should treat these risks with particular seriousness.

4. Endocrine suppression

Like all exogenous androgens, Equipoise suppresses the hypothalamic-pituitary-testicular axis (HPTA), reducing or eliminating natural testosterone production during the cycle. This is why post-cycle therapy is not optional. It’s a necessary step to restore hormonal function. Without PCT, prolonged testosterone suppression can result in low testosterone symptoms, loss of gains, and mood disturbances.

5. Organ stress

The liver and kidneys are involved in processing and eliminating steroid metabolites. Injectable steroids generally carry lower hepatotoxicity than oral 17α-alkylated compounds, but organ monitoring via bloodwork during and after a cycle is advisable. Unusually long or high-dose cycles increase cumulative organ stress.

Equipoise Dosage: Standard Ranges

Reported Equipoise dosages in bodybuilding contexts typically range as follows:

The Equipoise cycle length is most commonly 12 weeks due to the long undecylenate ester requiring several weeks to reach stable serum concentrations. Shorter cycles are considered less effective. Injection frequency is typically once or twice per week.

Injection sites

The most commonly reported injection sites are the glutes (gluteal muscles), outer thigh (vastus lateralis), and deltoids. Rotating sites between injections reduces localised tissue irritation and scar tissue accumulation.

Post-Cycle Therapy (PCT): Non-Negotiable

PCT is required after every Equipoise cycle, without exception. The purpose of PCT is to stimulate the body’s natural testosterone production, which is suppressed during a steroid cycle. Without it, users risk prolonged hypogonadism, mood disturbances, loss of cycle gains, and sexual dysfunction.

Standard PCT protocol (Equipoise cycle):

• Compounds: Clomid (Clomiphene Citrate) and/or Nolvadex (Tamoxifen Citrate)
• Start time: Approximately 2 weeks after the last Equipoise injection, to account for the long ester clearance time.
• Duration: Typically 4–6 weeks, depending on the cycle length and the compounds stacked.
• Specific doses: Should be determined in consultation with a medical professional based on the individual’s cycle and bloodwork.

Aromasin (Exemestane) may also be continued into early PCT in some protocols. Bloodwork before, during, and after the cycle is strongly recommended to monitor hormonal recovery.